This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The State University of New York. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Simon Tong: Innovator in Pharmaceutical Chemistry
Introduction
Simon Tong is a notable inventor based in Great Neck, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit the activity of Fatty Acid Binding Proteins (FABPs). With a total of two patents to his name, his work is recognized for its potential impact on medical science.
Latest Patents
One of Simon Tong's latest patents is focused on Alpha-truxillic acid derivatives and pharmaceutical compositions thereof. This invention provides a compound and a method for inhibiting the activity of FABP by contacting the FABP with a specific compound. The structure of this compound is detailed in the patent as Formula (I). This innovative approach has the potential to lead to new therapeutic options in treating various conditions.
Career Highlights
Simon Tong is affiliated with the State University of New York, where he continues to engage in research and development in the pharmaceutical field. His academic background and ongoing research contribute to the advancement of knowledge in drug development and therapeutic applications.
Collaborations
Some of Simon Tong's notable coworkers include Iwao Ojima and Dale Deutsch. Their collaborative efforts in research have further enhanced the impact of their work in the field of pharmaceutical chemistry.
Conclusion
In summary, Simon Tong is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the area of FABP inhibitors, highlight the importance of research in developing new medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
